Compounds > topotecan

Page last updated: 2024-08-24

topotecan and Hepatoblastoma

topotecan has been researched along with Hepatoblastoma in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Chang, J; Li, YN; Liu, ZL; Yao, YM; Zhang, YT; Zhong, XD	1
Cao, Y; Cheng, C; He, CL; Zhang, J; Zhou, YJ	1
Fuchs, J; Gratz, KF; Mildenberger, H; von Schweinitz, D; Warmann, SW; Wilkens, L	1
Huang, J; Kandel, JJ; Kim, ES; Manley, C; McCrudden, KW; Middlesworth, W; O'toole, K; Soffer, SZ; Thosani, A; Yamashiro, DJ; Yokoi, A	1

Other Studies

4 other study(ies) available for topotecan and Hepatoblastoma

Article	Year
Novel treatment of refractory / recurrent pulmonary hepatoblastoma. Pediatrics international : official journal of the Japan Pediatric Society, 2020, Volume: 62, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Female; Hepatoblastoma; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Oxaliplatin; Radiofrequency Ablation; Retrospective Studies; Survival Rate; Topotecan; Treatment Outcome; Vincristine	2020
The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line. Cancer investigation, 2008, Volume: 26, Issue:5 Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p27; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Hepatoblastoma; Humans; Immunohistochemistry; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Microscopy, Electron, Transmission; RNA Interference; Signal Transduction; Time Factors; Topoisomerase I Inhibitors; Topotecan; Transfection	2008
Successful therapy of subcutaneously growing human hepatoblastoma xenografts with topotecan. Medical and pediatric oncology, 2001, Volume: 37, Issue:5 Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Cell Division; Hepatoblastoma; Humans; Immunohistochemistry; Infant, Newborn; Infusions, Parenteral; Liver Neoplasms; Mice; Mice, Nude; Necrosis; Neoplasms, Experimental; Topotecan; Transplantation, Heterologous	2001
Topotecan is anti-angiogenic in experimental hepatoblastoma. Journal of pediatric surgery, 2002, Volume: 37, Issue:6 Topics: Angiogenesis Inhibitors; Animals; Female; Hepatoblastoma; Humans; Liver Neoplasms, Experimental; Lung Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; Topotecan; Transplantation, Heterologous; Tumor Cells, Cultured	2002